Immune checkpoint inhibitors⁃related nervous system adverse events

Immune checkpoint inhibitors (ICIs) have been widely used in tumor treatment. Immune⁃related adverse events (irAEs) are common in skin, endocrine, gastrointestinal tract, liver and cardiovascular system symptoms. Nervous system adverse events are relatively rare, but the clinical presentations are v...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Chinese Journal of Contemporary Neurology and Neurosurgery
المؤلفون الرئيسيون:	WANG Ze⁃yi, LIU Guang⁃zhi
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Tianjin Huanhu Hospital 2022-09-01
الموضوعات:	neoplasms immunosuppressive agents drug ⁃ related side effects and adverse reactions nervous system review
الوصول للمادة أونلاين:	http://www.cjcnn.org/index.php/cjcnn/article/view/2558

مواد مشابهة

Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events
حسب: Min Kyu Kim, وآخرون
منشور في: (2024-11-01)

Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
حسب: Parneet K. Cheema, وآخرون
منشور في: (2024-10-01)

Ideas for the Diagnosis and Treatment of Multisystem Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors
حسب: ZHANG Yanjing, SONG Xiaokun
منشور في: (2023-08-01)

Risk of autoimmunity, cancer seeding, and adverse events in human trials of whole-tissue autologous therapeutic vaccines
حسب: Garrett Gianneschi, وآخرون
منشور في: (2025-03-01)

Risk factors associated with adverse reactions to antituberculosis drugs
حسب: Laíse Soares Oliveira Resende, وآخرون
منشور في: (2015-02-01)

Incidence, characteristics, and clinical impact of serious adverse events in patients with breast cancer receiving antineoplastic treatment in the ambulatory setting
حسب: Zahieh AbuAloush, وآخرون
منشور في: (2024-12-01)

Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review
حسب: Paulo Nunes Filho, وآخرون
منشور في: (2023-03-01)

Advancing precision medicine: Uncovering biomarkers and strategies to mitigate immune-related adverse events in immune checkpoint inhibitors therapy
حسب: K.L. Nityashree, وآخرون
منشور في: (2025-06-01)

Clinical characteristics of anti-neuronal antibody positive paraneoplastic neurological syndrome related to immune checkpoint inhibitors
حسب: ZHANG Le, وآخرون
منشور في: (2024-05-01)

Prevalence and Management of Immediate Adverse Reactions to Chemotherapy in Breast Cancer Patients: A Retrospective Study
حسب: Guillermo Insfran, وآخرون
منشور في: (2025-01-01)

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
حسب: Rilan Bai, وآخرون
منشور في: (2021-11-01)

Clinical outcomes of systemic anticancer therapies in solid cancer patients with liver and kidney transplant: an observational cross-sectional study
حسب: E. Chen, وآخرون
منشور في: (2025-12-01)

Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors
حسب: Sotiria Stavropoulou De Lorenzo, وآخرون
منشور في: (2024-06-01)

Adverse drug reactions associated with sunitinib therapy: Characteristics and risk factors
حسب: Mugoša Snežana, وآخرون
منشور في: (2021-01-01)

Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review
حسب: Sung Wook Hwang, وآخرون
منشور في: (2023-10-01)

Immune-Related Adverse Event-Related Adrenal Insufficiency Mediates Immune Checkpoint Inhibitors Efficacy in Cancer Treatment
حسب: Zhang S, وآخرون
منشور في: (2024-03-01)

Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
حسب: Prasanna Duraisamy, وآخرون
منشور في: (2023-07-01)

The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes
حسب: Hamzah Abu-Sbeih, وآخرون
منشور في: (2018-07-01)

Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system
حسب: Yifeng Bai, وآخرون
منشور في: (2024-10-01)

The Utility of the Liverpool Adverse Drug Reaction Assessment Tools in the Evaluation of Chemotherapy-Induced Nausea and Vomiting in Children
حسب: Elisangela Costa Lima, وآخرون
منشور في: (2023-07-01)

Adverse Drug Reactions Among Hospitalized Psychiatric Patients, Prevalence, Severity, Preventability, and Opportunities for Intervention
حسب: Asma Al Hindi, وآخرون
منشور في: (2024-05-01)

Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis
حسب: Xin Shen, وآخرون
منشور في: (2024-05-01)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
حسب: Yujin Choi, وآخرون
منشور في: (2024-10-01)

Mortality and years of life lost related to adverse drug events in Brazil
حسب: Lunara Teles Silva, وآخرون
منشور في: (2024-05-01)

Incidence and risk factors for dermatologic adverse events following apalutamide use: a real-world data analysis in the Korean population
حسب: Sangmin Lee, وآخرون
منشور في: (2025-03-01)

Adverse drug reactions following treatment of latent tuberculosis infection: a linked national tuberculosis surveillance with claims database
حسب: Yu-Seon Jung, وآخرون
منشور في: (2024-11-01)

Rituximab use in adult glomerulopathies and its rationale
حسب: Joana Eugénio Santos, وآخرون
منشور في: (2019-12-01)

Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
حسب: Mariana Ornelas, وآخرون
منشور في: (2023-07-01)

Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
حسب: Jade Cury-Martins, وآخرون
منشور في: (2020-07-01)

Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
حسب: Abdul Rafeh Naqash, وآخرون
منشور في: (2019-07-01)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
حسب: Walid Shalata, وآخرون
منشور في: (2023-07-01)

Adverse effects of immunosuppressive therapy after kidney transplant
حسب: S. V. Popov, وآخرون
منشور في: (2025-03-01)

Trackers for Adverse Events in Child Mental Health: descriptive analysis using the global trigger tool
حسب: Sandna Larissa Freitas dos Santos, وآخرون
منشور في: (2023-10-01)

Pancreatic adverse events in patients treated with immune checkpoint inhibitors
حسب: Caroline Hana, وآخرون
منشور في: (2023-03-01)

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
حسب: Jiaxin ZHOU, وآخرون
منشور في: (2019-10-01)

Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)
حسب: M. Yu. Fedyanin, وآخرون
منشور في: (2023-06-01)

Clinical Challenges of the COVID-19 Vaccines: Frequency of Serious Adverse Events After Immunization in Hospitalized Patients
حسب: Hamed Delam, وآخرون
منشور في: (2023-12-01)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
حسب: Lingli Luo, وآخرون
منشور في: (2023-04-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system
حسب: Yue Li, وآخرون
منشور في: (2020-04-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
حسب: Xiaoyan Si, وآخرون
منشور في: (2020-02-01)